|
|
|
|
Document Preview Indenture |
|
|
|
|
|
Click "Add to Cart" button to purchase document. |
|
|
|
|
|
Title: |
Indenture |
|
Entities: |
Cede & Co.; Hybridon, Inc.; ISIS Pharmaceuticals, Inc.; Robertson Stephens, Inc.; Roth Capital Partners, LLC; UBS Warburg LLC; Wells Fargo Bank Minnesota, NA; UBS AG; Cooley Godward LLP; Dewey Ballantine LLP |
|
Date: |
2002 |
|
Size: |
320KB total |
|
Price: |
$85 |
|
ID: |
#282207 |
|
|
|
|
|
|
|
Start of Preview |
|
ISIS PHARMACEUTICALS, INC.
and
WELLS FARGO BANK MINNESOTA, NATIONAL ASSOCIATION
as Trustee
INDENTURE
Dated as of May 1, 2002
$125,000,000 Principal Amount
(Plus Over-allotment Option)
5 ?% CONVERTIBLE SUBORDINATED NOTES DUE 2009
CROSS-REFERENCE TABLE
|
TIA Section |
|
Indenture Section | |
|
|
|
|
|
|
310 |
(a)(1) |
|
7.10 |
|
|
(a)(2) |
|
7.10 |
|
|
(a)(3) |
|
N.A. |
|
|
(a)(4) |
|
N.A. |
|
|
(b) |
|
7.08; 7.10; 12.02 |
|
|
(c) |
|
N.A. |
|
311 |
(a) |
|
7.11 |
|
|
(b) |
|
7.11 |
|
|
(c) |
|
N.A. |
|
312 |
(a) |
|
2.05 |
|
|
(b) |
|
12.03 |
|
|
(c) |
|
12.03 |
|
313 |
(a) |
|
7.06 |
|
|
(b)(1) |
|
N.A. |
|
|
(b)(2) |
|
7.06 |
|
|
(c) |
|
7.06; 12.02 |
|
|
(d) |
|
7.06 |
|
314 |
(a) |
|
4.03 |
|
|
(b) |
|
N.A. |
|
|
(c)(1) |
|
12.04 |
|
|
(c)(2) |
|
12.04 |
|
|
(c)(3) |
|
N.A. |
|
|
(d) |
|
N.A. |
|
|
(e) |
|
12.05 |
|
|
(f) |
|
N.A. |
|
315 |
(a) |
|
7.01(B) |
|
|
(b) |
|
7.05; 12.02 |
|
|
(c) |
|
7.01(A) |
|
|
(d) |
|
7.01(C) |
|
|
(e) |
|
6.11 |
|
316 |
(a)(last sentence) |
|
2.09 |
|
|
(a)(1)(A) |
|
6.05 |
|
|
(a)(1)(B) |
|
6.04 |
|
|
(a)(2) |
|
N.A. |
|
|
(b) |
|
6.07 |
|
317 |
(a)(1) |
|
6.08 |
|
|
(a)(2) |
|
6.09 |
|
|
(b) |
|
2.04 |
|
318 |
(a) |
|
12.01 |
N.A. means Not Applicable
Note: This Cross-Reference Table shall npt, for any purpose, be deemed to be a part of the Indenture
TABLE OF CONTENTS